Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma), Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) – 2020 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: April 9, 2020
Clear
SKU: GMS-3146 Category:

The global market for Cancer Diagnostics is expected to hit USD 22.3 billion by 2025, rising in 2020-2025 at a CAGR of 12.63%. Technological advancements in various fields such as biomarkers, imaging, biopsy, endoscopy; growing numbers of cancer cases, rapid increase in geriatric population, policy awareness initiatives, and increasing government funding are key drivers of market development.

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 1

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 2

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 3

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 4

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 5

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 6

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 7

Cancer Diagnostics Market by Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma),  Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging, Biopsy) - 2020 to 2025 8

1 Global Cancer Diagnostics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Cancer Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Cancer Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Cancer Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Cancer Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Cancer Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Cancer Diagnostics Market – By Technology (Market Size – & million/billion)
8.1 Platform-based
8.2 Instrument-based

9 Global Cancer Diagnostics Market – By Application
9.1 Breast Cancer
9.2 Lung Cancer
9.3 Colorectal Cancer
9.4 Melanoma
9.5 Others

10 Global Cancer Diagnostics Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Cancer Diagnostics Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Cancer Diagnostics Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Abbott
12.3 GE Healthcare
12.4 Becton, Dickinson and Company
12.5 Agilent Technologies, Inc.
12.6 Thermo Fisher Scientific, Inc.
12.7 Roche
12.8 C.R. Bard, Inc.
12.9 Illumina, Inc.
12.10 Siemens Healthcare
12.11 Company 10
12.12 Company 11 & more

13 Global Cancer Diagnostics Market – Appendix
13.1 Sources
13.2 Abbreviations